Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost.

CONCLUSION: Bimatoprost monotherapy and brinzolamide adjunctive to latanoprost similarly reduced the IOP, with no additive adverse effects, compared with latanoprost monotherapy. PMID: 27073587 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/27073587?dopt=Abstract

Source: Open Ophthalmology Journal - April 15, 2016 Category: Opthalmology Tags: Open Ophthalmol J Source Type: research